Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE

(ABBV)
  Report  
Delayed Quote. Delayed Nyse - 11/19 04:02:44 pm
89.02 USD   +0.33%
09:34aABBVIE : Form 8.3 - -2-
DJ
09:34aABBVIE : Form 8.3 -
DJ
11/18ALLERGAN : Form 8.3 -
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/13/2019 11/14/2019 11/15/2019 11/18/2019 11/19/2019 Date
86.66(c) 87.63(c) 88.63(c) 88.73(c) 89.02(c) Last
6 012 601 5 426 584 8 041 385 5 773 575 7 455 595 Volume
+0.25% +1.12% +1.14% +0.11% +0.33% Change
More quotes
Financials (USD)
Sales 2019 33 293 M
EBIT 2019 15 768 M
Net income 2019 8 578 M
Debt 2019 30 704 M
Yield 2019 4,83%
Sales 2020 35 501 M
EBIT 2020 17 096 M
Net income 2020 10 741 M
Debt 2020 22 995 M
Yield 2020 5,38%
P/E ratio 2019 14,9x
P/E ratio 2020 9,73x
EV / Sales2019 4,88x
EV / Sales2020 4,36x
Capitalization 132 B
More Financials
Company
AbbVie specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with... 
Sector
Pharmaceuticals
Calendar
01/14Ex-dividend day for
More about the company
Surperformance© ratings of AbbVie
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE
09:34aABBVIE : Form 8.3 - -2-
DJ
09:34aABBVIE : Form 8.3 -
DJ
11/18ALLERGAN : Form 8.3 -
DJ
11/18ABBVIE : Form 8.3 -
DJ
11/18ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/18ABBVIE : Announces Extension of Expiration Date for Exchange Offers for Allergan..
PR
11/18PFIZER : FDA Approves Humira Biosimilar Abrilada for Multiple Conditions
DJ
11/15ABBVIE : Form 8.3 -
DJ
11/14Rising Treasury Yields Quiet Investors' Concerns -- 2nd Update
DJ
11/14Rising Treasury Yields Quiet Investors' Concerns -- Update
DJ
11/14ABBVIE : Form 8.3 - -2-
DJ
11/14ABBVIE : Form 8.3 -
DJ
11/14Abbott's White To Step Down as Chief Executive -- WSJ
DJ
11/13ABBVIE INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
11/13Longtime Abbott Labs CEO Miles White to Step Down in March -- 2nd Update
DJ
More news
News in other languages on ABBVIE
11/01Bourse Zurich: le SMI termine la semaine sur une note positive
11/01ABBVIE : fourchette cible de BPA resserrée en hausse
11/01Les valeurs à suivre aujourd'hui à Wall Street Vendredi 1er novembre 2019
11/01ABBVIE : dépasse les attentes, relève ses prévisions et le dividende
11/01Séance calme avant le rapport sur l'emploi US
More news
Analyst Recommendations on ABBVIE
More recommendations
Sector news : Pharmaceuticals - NEC
05:38pAkcea, Ionis Close Licensing Agreement with Pfizer on New Drug
DJ
05:18pAlcon Posts 3Q Loss and Will Restructure Operations
DJ
01:07pMERCK AND : & Co. Raises Quarterly Dividend by 10.9% to 61 Cents
DJ
11:41aGENMAB : EC Approves Expanded Darzalex Use in Multiple Myeloma
DJ
11:02aMEDICINES : Shares Up 19% After Bloomberg Report
DJ
More sector news : Pharmaceuticals - NEC
Chart ABBVIE
Duration : Period :
AbbVie Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 94,36  $
Last Close Price 89,02  $
Spread / Highest target 46,0%
Spread / Average Target 6,00%
Spread / Lowest Target -9,01%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Senior Vice President
Carlos Alban Vice Chairman & Chief Commercial Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE-3.75%131 216
JOHNSON & JOHNSON4.56%354 855
ROCHE HOLDING AG21.63%259 443
MERCK AND COMPANY10.10%214 194
PFIZER-14.73%205 980
NOVARTIS19.39%204 533